JPWO2020001643A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020001643A5 JPWO2020001643A5 JP2020572804A JP2020572804A JPWO2020001643A5 JP WO2020001643 A5 JPWO2020001643 A5 JP WO2020001643A5 JP 2020572804 A JP2020572804 A JP 2020572804A JP 2020572804 A JP2020572804 A JP 2020572804A JP WO2020001643 A5 JPWO2020001643 A5 JP WO2020001643A5
- Authority
- JP
- Japan
- Prior art keywords
- diacid
- total weight
- mannurone
- pharmaceutical composition
- mannuron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 18
- 229920001542 oligosaccharide Polymers 0.000 claims 17
- 150000002482 oligosaccharides Chemical class 0.000 claims 17
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 239000002253 acid Substances 0.000 claims 8
- 235000000346 sugar Nutrition 0.000 claims 6
- 150000008163 sugars Chemical class 0.000 claims 6
- 150000002016 disaccharides Chemical class 0.000 claims 3
- 238000006116 polymerization reaction Methods 0.000 claims 3
- 150000004044 tetrasaccharides Chemical class 0.000 claims 3
- 150000004043 trisaccharides Chemical class 0.000 claims 3
- 201000004810 Vascular dementia Diseases 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- 159000000000 sodium salts Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810711863.8 | 2018-06-29 | ||
| CN201810711863.8A CN110652523A (zh) | 2018-06-29 | 2018-06-29 | 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用 |
| PCT/CN2019/093813 WO2020001643A1 (zh) | 2018-06-29 | 2019-06-28 | 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021528458A JP2021528458A (ja) | 2021-10-21 |
| JPWO2020001643A5 true JPWO2020001643A5 (enExample) | 2022-07-05 |
Family
ID=68985857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020572804A Pending JP2021528458A (ja) | 2018-06-29 | 2019-06-28 | 血管性認知症の治療におけるマンヌロン二酸組成物の使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11406651B2 (enExample) |
| EP (1) | EP3815694A4 (enExample) |
| JP (1) | JP2021528458A (enExample) |
| KR (1) | KR20210040039A (enExample) |
| CN (1) | CN110652523A (enExample) |
| AU (1) | AU2019296854A1 (enExample) |
| WO (1) | WO2020001643A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1562050A (zh) * | 2004-03-24 | 2005-01-12 | 中国海洋大学 | 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用 |
| CN106344592A (zh) | 2015-07-17 | 2017-01-25 | 上海绿谷制药有限公司 | 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用 |
| CN106344593B (zh) * | 2015-07-17 | 2020-01-10 | 上海绿谷制药有限公司 | 褐藻胶寡糖及其衍生物在制备治疗血管性痴呆药物中的应用 |
| AU2017385332B2 (en) * | 2016-12-30 | 2020-10-29 | Shanghai Green Valley Pharmaceutical Co., Ltd. | Composition of mannuronic dicarboxylic acid |
-
2018
- 2018-06-29 CN CN201810711863.8A patent/CN110652523A/zh active Pending
-
2019
- 2019-06-28 WO PCT/CN2019/093813 patent/WO2020001643A1/zh not_active Ceased
- 2019-06-28 US US17/256,738 patent/US11406651B2/en active Active
- 2019-06-28 EP EP19826046.5A patent/EP3815694A4/en not_active Withdrawn
- 2019-06-28 AU AU2019296854A patent/AU2019296854A1/en not_active Abandoned
- 2019-06-28 JP JP2020572804A patent/JP2021528458A/ja active Pending
- 2019-06-28 KR KR1020217001545A patent/KR20210040039A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6214750B2 (ja) | 低用量トピラメート／フェンテルミン組成物およびその使用方法 | |
| EP1496917B1 (en) | Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders | |
| ES2656613T3 (es) | Glicosaminoglicanos no anticoagulantes que comprenden unidades de repetición de disacáridos y su uso médico | |
| EP2034956B1 (en) | Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis | |
| JPWO1993013781A1 (ja) | コレステロール低下剤 | |
| KR20160008496A (ko) | 헤파리노이드, 급성 작용성 마취제 및 버퍼를 포함하는 안정한 조성물 | |
| JP2011037849A (ja) | 消化性潰瘍及び十二指腸潰瘍の治療及び予防に使用されるヒアルロン酸混合物 | |
| CN101621997B (zh) | 医药组合物 | |
| FR2568774A2 (fr) | Medicaments favorisant les proprietes d'ecoulement du sang et leur utilisation en therapeutique | |
| JPWO2020001643A5 (enExample) | ||
| JPWO2020001640A5 (enExample) | ||
| JPWO2020001644A5 (enExample) | ||
| JP2012526099A5 (enExample) | ||
| US20060058261A1 (en) | Chitin derivatives for hyperlipidemia | |
| JP2006528614A5 (enExample) | ||
| AU2010224510A1 (en) | A dose of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment | |
| JPWO2019232130A5 (enExample) | ||
| JPWO2020001611A5 (enExample) | ||
| JPWO2023078333A5 (enExample) | ||
| US20150174245A1 (en) | Transparent gel | |
| JPH08208750A (ja) | 非架橋型陰イオン交換樹脂 | |
| JPH10338638A (ja) | 損傷皮膚修復用製剤 | |
| JPWO2020001639A5 (enExample) | ||
| JP2005509663A5 (enExample) | ||
| EP3250212B1 (en) | Combination of hyaluronic acid and macrogol and pharmaceutical compositions containing it |